University of Brighton   Report issue

Academic/Hospital Phase 4
Founded: Brighton United Kingdom (1858)

Organization Overview

First Clinical Trial
2012
NCT01431859
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Brighton and Sussex University Hospital NHS Trust | Brighton and Sussex University Hospital Trust | Brighton & Sussex Medical School/Brighton & Sussex Universitys NHS Trust | University of Brighton

Active Ingredients

Drugs in Phase 4 Trials (4)

birch allergen (1 trial)

montelukast (singulair) (1 trial)

salmeterol (serevent) (1 trial)

theophylline (synophylate) (1 trial)

Drugs in Other Trials (1)

egg (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 4)

Hypersensitivity (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5